Physician

Brett Robert Barlow, M.D.

According to 2025 Medicare claims, Brett Barlow, M.D. (NPI: 1700240264) practices hematology/oncology in the Florence-Muscle Shoals, AL market, with the plurality of this provider's patient population coming from Lauderdale, AL. This provider's primary affiliated billing organization is ONCOLOGY SPECIALTIES, P.C. (NPI: 1669425716; TIN: 630897317) and primary practice location at 35630-3263. Barlow is affiliated with the Huntsville ACO (ACO ID: A3579), participating under the MSSP model.

Barlow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 847 traditional Medicare patients, billed 175,261 HCPCS/CPT codes, and received $3,153,096 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 1,868 prescription claims across 294 beneficiaries totaling $4,723,274 in drug costs, led by Xtandi (Enzalutamide). DME data shows 79 claims. Open Payments data shows 160 records totaling $3,124. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $431 to $4,723,274. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	224	17,918	$255,868
2023	756	176,221	$2,869,853
2024	847	175,261	$3,153,096

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	18	$431
2017	11	29	$488
2018	N/R	13	$242
2019	14	27	$45,240
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	39	158	$107,724
2023	202	1,109	$3,031,437
2024	294	1,868	$4,723,274

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	49	$19,064
2024	N/R	79	$1,754

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82728	Ferritin (blood protein) level	366	649	$13
80053	Blood test, comprehensive group of blood chemicals	712	2,070	$10
36415	Insertion of needle into vein for collection of blood sample	725	2,178	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	730	2,194	$8
83540	Iron level	364	642	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	42	1,260	$581,910
Erleada	Apalutamide	38	1,140	$535,909
Brukinsa	Zanubrutinib	40	1,200	$430,603
Revlimid	Lenalidomide	29	707	$412,786
Calquence	Acalabrutinib Maleate	11	330	$338,218

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	26	$1,031
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	23	$351
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$263
J8520	Capecitabine, oral, 150 mg	N	N/R	15	$108

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	160	$3,124	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brett Robert Barlow, M.D.?

Tedicare shows public-source Medicare data for Brett Robert Barlow, M.D. (NPI 1700240264), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brett Robert Barlow, M.D. have ACO affiliation data?

Brett Robert Barlow, M.D. is shown with ACO affiliation data for Huntsville ACO (MSSP, ACO ID A3579).

What billing organization is linked to Brett Robert Barlow, M.D.?

Brett Robert Barlow, M.D. is linked to ONCOLOGY SPECIALTIES, P.C. (billing NPI 1669425716) in the available physician profile data.

Does Brett Robert Barlow, M.D. have Open Payments data?

Brett Robert Barlow, M.D. has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.